Skip to main content

Advertisement

Log in

Retinopathy from hydroxychloroquine is not related to lupus or rheumatoid arthritis

  • Letter to the Editor
  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 30 January 2018

The Original Article was published on 29 August 2017

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Telek HH, Yesilirmak N, Sungur G et al (2017) Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis. Doc Ophthalmol 135:187–194

    Article  PubMed  Google Scholar 

  2. Marmor MF, Kellner U, Lai TY et al (2016) American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopthy. Ophthalmology 123:1386–1394

    Article  PubMed  Google Scholar 

  3. Melles RB, Marmor MF (2014) The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol 132(12):1453–1460

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael F. Marmor.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marmor, M.F. Retinopathy from hydroxychloroquine is not related to lupus or rheumatoid arthritis. Doc Ophthalmol 136, 93–94 (2018). https://doi.org/10.1007/s10633-018-9623-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10633-018-9623-4

Navigation